This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Kim S Y, Salomon J A, Goldie S J. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bulletin of the World Health Organization 2007; 85(11): 833-842
Subject indexing assigned by NLM
Cost-Benefit Analysis; Developing Countries /economics; Gambia /epidemiology; Health Policy; Hepatitis B /epidemiology; Hepatitis B Vaccines /economics /therapeutic use; Humans; Infant; Models, Econometric; Monte Carlo Method; Prevalence; Risk Factors
Date bibliographic record published